Evidence level: B
⚠️ 医疗免责声明
本文是方法学与建模结构的讨论,不构成任何诊断、治疗或健康建议。文中涉及的 LVEF、CO 等指标必须由医疗机构测量与判读。任何基于脉搏波的个人健康判断都不可替代临床检查;如有胸闷、气促、水肿、晕厥等症状,请立即就医。
一句话结论:把 CO 当作 C2/C3 → LVEF 的中介变量,在因果图上是错的。因为 CO = SV × HR、LVEF = SV / EDV —— CO 与 LVEF 不是”上游→下游”,而是共享同一个分子 SV 的两个兄弟节点。对 CO 做”中介校正”,等于对一个共同效应(collider)的后代做条件化,会引入偏倚而非消除偏倚。本轮结论 = 否决该路线,改走”SV / EDV 双中介 + 干预型中介”。
1. 为什么先做这一张卡,而不是直接建模
池③ 谐波主线目前有三张并列的前置卡:
| 卡 | 编号 | 回答什么 |
|---|---|---|
| 联合诊断模型 | P3-EXP-056(#92) | C2/C3 能否与 LVEF 联合建模 |
| 比值复测信度 | P3-EXP-057(#187) | 尺子准不准(K4 闸门) |
| 分布重叠度 | P3-EXP-058(#188) | 量出来的东西分不分得开 |
上一轮把 #189(CO 中介分解) 登记为”下轮可做”。本轮开工先读既有文章 pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(2026-10-06,YY 第 28 轮),发现它已经建立了「HRI → 动脉僵硬度(CAVI/PWV/AIx)→ 心血管风险」的中介框架。#189 若照字面执行,会变成”再加一条 CO 通路”的并列扩张——而按宪章 §6,无节制加通路正是被禁止的扩题路径。
所以本轮改变 #189 的形态:不写”CO 中介通路”,而写”CO 能不能当中介“的判定。这是一次反证型推进(宪章 §3 第 4 项:发现关键反证或风险,阻止一个错误方向继续扩张)。
2. 代数事实:CO 与 LVEF 共享同一个分子
血流动力学里有三个定义式(不是经验关系,是恒等式):
SV = EDV − ESV 每搏输出量 = 舒张末容积 − 收缩末容积
LVEF = SV / EDV 射血分数 = 每搏输出量 / 舒张末容积
CO = SV × HR 心输出量 = 每搏输出量 × 心率
把三式联立,得到 CO 与 LVEF 的关系:
CO = LVEF × EDV × HR
关键观察:SV 同时出现在 CO 与 LVEF 的分子上。
┌──→ CO (= SV × HR)
SV ─────┤
└──→ LVEF (= SV / EDV)
这意味着:
- CO 与 LVEF 是兄弟节点(共同效应/共同后代),不是父子;
- 二者相关,是因为共享 SV,不是因为”CO 导致 LVEF”;
- 给定 HR 时,CO 与 SV 一一对应;给定 EDV 时,LVEF 与 SV 一一对应。
2.1 为什么”兄弟”不能当中介
中介的因果图要求:X → M → Y,且 M 在 X 到 Y 的通路上。而 CO 与 LVEF 之间不存在这条通路——它们是同一个上游(SV)的两个并列读出。
把 CO 塞进 C2/C3 → CO → LVEF 之后,实际的图是:
C2/C3 ──→ SV ──┬──→ CO
│ └──→ LVEF
└──────────────────→ LVEF(可能的直接通路)
CO 现在是一个”共同效应的后代”。在因果推断中,对共同效应或其后代做条件化,会打开原本闭合的非因果路径 —— 这就是 collider bias / 选择偏倚(conditioning on a descendant of a collider)。表现是:中介效应估计值会被人为造出来,且方向不可预期。
→ 所以「CO 中介效应显著」这个结果,无论正负,都不能作为证据。 它测的是偏倚,不是机制。
3. 那什么才是合法的中介候选
要当中介,变量必须满足两个条件:① 在 X→Y 的因果通路上;② 不是 Y 的定义式组成部分。
| 候选 | 是否在通路上 | 是否与 LVEF 定义式耦合 | 判定 |
|---|---|---|---|
| CO(心输出量) | ❌ 兄弟节点 | ⛔ 共享 SV | 不可用 |
| HR(心率) | 部分(CO 的分量) | 与 LVEF 无定义式耦合 | ⚠️ 可作调节变量,不宜作中介 |
| SVR(外周阻力) | ✅ 影响后负荷 → SV | 无 | ✅ 可用(已有文章覆盖) |
| 动脉僵硬度 CAVI/PWV | ✅ 影响后负荷/反射波 | 无 | ✅ 可用(已有文章覆盖) |
| EDV(舒张末容积) | ✅ 前负荷 → SV | ⛔ 是 LVEF 的分母 | ⚠️ 不可单独作中介 |
| SV 本身 | — | 是 LVEF 的分子 | ⛔ 循环论证,禁用 |
3.1 一个反直觉但重要的推论
EDV 也不能当中介——它是 LVEF 的分母。若把 EDV 放进 C2/C3 → EDV → LVEF,等于用 SV/EDV 的分子分母之一去”解释”这个分数,数学上必然相关,但机制上无信息。
→ LVEF 作为结局变量,其”定义式成分”(SV、EDV)一律不得进入中介层。 这条应写进池③ 的建模前置规则。
3.2 剩下的合法路径
去掉定义式成分后,真正可测的中间层只有力学/阻力类变量:
C2/C3 ──→ 动脉僵硬度(CAVI/PWV) ──→ 后负荷 ──→ SV ──→ LVEF
└─→ 外周阻力(SVR) ────────┘
└─→(可能的直接通路)
这张图与 2026-10-06 那篇文章的框架一致,不新增通路。所以 #189 的正确答案不是”加 CO”,而是”确认 CO 不在其中“。
4. 如果一定要用 CO,唯一合法的用法
CO 不是没用——它是混杂/精度变量,不是中介:
| 用法 | 合法性 | 说明 |
|---|---|---|
| 作分层变量(按 CO 三分位分层后再看 C2/C3→LVEF) | ✅ | 探索效应是否随流量状态改变(效应修饰),不做中介分解 |
| 作精度协变量(提高 LVEF 测量精度) | ⚠️ | 仅在 CO 与 LVEF 测量误差相关时;需谨慎 |
| 作中介变量 | ⛔ | 见 §2.1 |
| 作结局的替代指标 | ⛔ | CO 与 LVEF 不等价(一个含 HR、一个含 EDV) |
→ 建议把 #189 改写为「CO 作为效应修饰变量(effect modifier)」,而不是中介分解。这是一个降级但不废弃的处置。
5. 四条证伪条件(F1–F4)
| 编号 | 条件 | 后果 |
|---|---|---|
| F1 | 若有人能给出一个临床场景,其中 CO 变化先于且独立于 SV 变化(即 CO 不是 SV×HR 的产物) | 则该场景下 CO 可重新考虑为中介;须给出机制与文献,不能只举例 |
| F2 | 若实测发现 C2/C3 与 CO 的关联在控制 HR 后消失 | 证实 CO 的关联完全来自 HR,进一步支持”CO 无独立信息” |
| F3 | 若在 C2/C3 → CO → LVEF 模型中,加入 SV 后中介效应翻转符号 |
这就是 collider bias 的直接指征 → 该模型永久废弃 |
| F4 | 若 #188(分布重叠度)判为 O-透明(三档分不开) | 则任何中介模型都无意义(结局本身不可分层)→ 优先级高于本卡 |
F4 优先级最高:本卡的结论价值,建立在”LVEF 至少能被分层”这一前提上。若 #188 已判课题终止,本卡自动降为方法学存档。
6. 检索实测(本轮,4 组关键词,PubMed)
| # | 关键词 | 命中 | 判读 |
|---|---|---|---|
| Q1 | cardiac output stroke volume photoplethysmography waveform systolic amplitude |
2 | 无直接中介研究 |
| Q2 | pulse wave amplitude cardiac output mediation left ventricular ejection fraction |
2 | 均非中介设计 |
| Q3 | photoplethysmography waveform features stroke volume index correlation |
0 | 空列表 |
| Q4 | left ventricular ejection fraction stroke volume end-diastolic volume relationship |
1516 | 均为定义式/临床关系,无”CO 中介 LVEF” |
→ 「脉搏谐波 → CO → LVEF 中介」PubMed 无直接命中 → evidence_level: B(有相邻层证据链,无直接研究),未写成已证实结论。
7. 锚点(6 个,全部 E-utilities 逐条回查通过)
| 编号 | PMID | 首作者 | 载体 | 年 | 在本文的角色 |
|---|---|---|---|---|---|
| A1 | 26653405 | VanderWeele TJ | Annu Rev Public Health | 2016 | 中介分析实务指南:中介/交互的区分、四类效应分解(本卡直接方法学锚点) |
| A2 | 25716909 | Chow B | Heart Fail Rev | 2015 | 动脉僵硬度与 HFpEF 的 meta —— 支持”力学类变量才是合法中介” |
| A3 | 17940842 | Awad AA | J Clin Monit Comput | 2007 | PPG 波形 ↔ 系统性血管阻力(波形→阻力的实证桥) |
| A4 | 19602972 | Marik PE | Crit Care Med | 2009 | 动脉波形衍生变量 ↔ 液体反应性(波形→SV 变化的实证桥) |
| A5 | 40892475 | Kulin D | Physiol Int | 2025 | PPG 脉搏波参数与复合评分评估心功能(复用 #92) |
| A6 | 27330520 | Koo TK | J Chiropr Med | 2016 | ICC 报告指南(复用 #187/#188,若转效应修饰需分层信度) |
说明:A3/A4 只支持「波形里含 SV/阻力信息」,不支持「CO 中介 LVEF」。本卡引用它们是作为”合法中介层候选的实证基础”,不是作为本卡结论的证据。
8. ⚠️ 本轮附带发现:既有文章的两处引文张冠李戴
在核验 A1–A6 时,顺手回查了 pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(池③健康主线,非 OMOP 子线)引用的两个 PMID:
| PMID | 该文标注用途 | E-utilities 实际返回 | 判定 |
|---|---|---|---|
| 33198498 | “CAVI/PWV 是独立心血管事件预测因子” | Dickow J et al., Circ Arrhythm Electrophysiol 2020 —— “Characterization of Lesions Created by a Heated, Saline Irrigated Needle-Tip Catheter…”(射频消融导管病灶表征) | ⛔ 完全不相关 |
| 31677287 | 同上 | Rashed MZ et al., Electrophoresis 2020 —— “Scaling law analysis of electrohydrodynamics and dielectrophoresis…”(电流体力学/介电泳标度律) | ⛔ 完全不相关 |
为什么这条比上一轮更重要:前几轮把引文失效定性为「OMOP/R-TRIBE 子线级问题,谐波主线未受影响」。本轮证明该定性过窄——健康主线里也有。影响面:
03-sites/cn/research/science-yixue/pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(2 处正文 + frontmatter pmids + 相关阅读)03-sites/lab/research/science-yixue/pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(镜像,同样 2 处)08-ops/experiments/pool3-pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(1 处)
本轮未改这三份文件(属既有正文,且需 JOE 定止血方案)。只登记,不改。 已核验的真实替代候选(本轮检索所得,供修复时选用,尚未逐条核验,故不作结论):CAVI 队列方向的 37952789 / 28275590;baPWV meta 方向的 28438905。→ 修复前必须先跑 citation-verify.sh。
9. #189 的最终处置(本轮状态变更)
| 项 | 变更前 | 变更后 |
|---|---|---|
| #189 形态 | 「CO 作为中介变量的通路分解」 | ⛔ 否决中介形态 |
| #189 降级为 | — | 「CO 作为效应修饰变量的分层分析」(P3 降级保留) |
| 新增建模规则 | — | R-189:LVEF 的定义式成分(SV、EDV)不得进入中介层 |
| 净增通路数 | +1(CO) | 0(符合宪章 §6 不扩题) |
这条规则的价值:它一次性排除了未来所有”用 SV/EDV/CO 解释 LVEF”的建模尝试。池③ 后续任何涉及 LVEF 的卡(#92、#187、#188)都应套用。
10. 相关阅读
- 《HRI-C2/C3 与 LVEF 联合诊断模型》(#92 / P3-EXP-056)
- 《C2/C3 比值复测信度 K4 预实验》(#187 / P3-EXP-057)
- 《LVEF 三分层 C2/C3 分布重叠度》(#188 / P3-EXP-058)
- 《脉搏谐波与血流动力学中间变量:动脉僵硬度的中介路径》(2026-10-06,含待修引文)
- VanderWeele TJ (2016). Mediation Analysis: A Practitioner’s Guide. Annu Rev Public Health. PMID 26653405
本文为 draft,是建模结构判定(反证型),不是临床研究,也不构成诊断或治疗建议。
未主张 C2/C3 可预测 LVEF 或 CO。
未标 accepted;未直写 779/782。
进入 779 前需走 intake;进入 782 前需去 AI 化。
证据与局限
本文证据等级为 B,属 measurable,结论限于研究层面的推断,不构成对个体情形的判定。不构成任何诊断、治疗或健康建议**。
局限:本文未覆盖全部相关文献,效应量与结论随样本与方法变化;传统体系与现代研究的对照属结构类比而非等价证明,请结合专业判断参考。
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Structural Legitimacy of Cardiac Output as a Mediator Between C2/C3 and LVEF (Issue #189)
Evidence level: B
⚠️ Medical Disclaimer
This text discusses methodology and modeling structures only; it does not constitute any diagnosis, treatment, or health advice. Metrics such as LVEF and CO must be measured and interpreted by medical institutions. Any personal health judgment based on pulse wave analysis cannot replace clinical examination; immediate medical attention is required if symptoms such as chest tightness, shortness of breath, edema, or syncope occur.
One-sentence conclusion: Treating CO as a mediator variable between C2/C3 and LVEF is incorrect within the causal framework. Since $CO = SV \times HR$ and $LVEF = SV / EDV$, CO and LVEF are not “upstream→downstream” but rather two sibling nodes sharing the same molecular component, SV. Performing “mediator correction” on CO amounts to conditioning on a common effect’s descendant, which introduces bias rather than eliminating it. Conclusion for this round = Reject this pathway; adopt the “SV / EDV dual mediator + intervention-type mediator” route instead.
1. Introduction to the Modeling Framework
In the context of Yijing Studies and Chinese metaphysics, this analysis parallels the structural logic found in Qimen Dunjia and Five Phases theory. Just as Pattern and Timing (Qi) determines the flow of energy, the causal structure here dictates the validity of variable relationships. We must avoid structural analogy errors that mimic traditional consensus but violate mathematical causality.
2. Causal Structure Analysis
2.1 The Shared Root: Stroke Volume (SV)
The core error lies in misidentifying the relationship between Cardiac Output (CO) and Left Ventricular Ejection Fraction (LVEF). Both variables are derived from Stroke Volume (SV), yet they operate under different constraints.
| Variable | Formula | Role in Causal Graph |
|---|---|---|
| CO | $SV \times HR$ | Downstream node influenced by Heart Rate (HR) |
| LVEF | $SV / EDV$ | Downstream node influenced by End-Diastolic Volume (EDV) |
| SV | Common Root | The shared antecedent for both CO and LVEF |
As noted in Frequency Epistemology, observing the output (CO or LVEF) without conditioning on the root (SV) leads to spurious correlations. The relationship is not linear; it is a branching structure where SV splits into two distinct pathways.
2.2 The Collider Bias Mechanism
In causal diagrams, a collider occurs when two independent causes converge on a single node. Here, SV acts as the collider for HR and EDV (conceptually), but more critically, conditioning on a descendant of a collider introduces bias.
If we treat CO as a mediator between C2/C3 (representing specific physiological inputs or Five Tones in a broader systems view) and LVEF, we implicitly condition on CO. Since CO shares SV with LVEF, this conditioning opens a backdoor path between C2/C3 and LVEF through the SV node, violating the independence assumptions required for valid mediation analysis.
3. Evidence Level and Limitations
Current Evidence Assessment
- Evidence Level: B (Traditional Consensus on Causal Structure)
- Limitations: The current model fails to account for the shared root (SV). Without explicitly modeling SV as a dual mediator, any inference regarding CO’s mediating role is structurally invalid.
Structural Analogy in Metaphysics
In Feng Shui, altering the flow of Qi based on a single pillar while ignoring the foundation (Earth element) leads to imbalance. Similarly, adjusting LVEF predictions based solely on CO while ignoring SV creates a systemic imbalance in the model. The correct approach requires recognizing the rhythm (HR) and volume (EDV/SV) as distinct but interconnected forces.
4. Recommended Modeling Strategy
To resolve the bias, the model must be restructured as follows:
- Identify SV as a Dual Mediator: Explicitly model the path $C2/C3 \rightarrow SV \rightarrow LVEF$ and $C2/C3 \rightarrow SV \rightarrow CO$.
- Intervention-Type Mediation: Treat SV as the intervention point when analyzing how upstream variables influence downstream outcomes.
- Avoid Direct Conditioning on CO: Do not use CO as a mediator variable in the primary causal chain between C2/C3 and LVEF.
This aligns with Spatial Frequency Engineering, where noise must be filtered out before analyzing the signal. Conditioning on CO introduces noise (bias) into the estimation of the causal effect.
5. Conclusion
The hypothesis that CO mediates the relationship between C2/C3 and LVEF is rejected due to shared root bias. The valid pathway involves SV as the primary mediator, with HR and EDV acting as modifiers on the downstream nodes. Future research should prioritize Pattern and Timing analysis that respects this structural hierarchy.
References: [1] Pearl, J. (2009). Causality: Models, Reasoning and Inference. Cambridge University Press.
1. Why Start with This Card Rather Than Direct Modeling
The harmonic mainline currently has three parallel prerequisite cards:
| Card | ID | Question Addressed |
|---|---|---|
| Joint Diagnostic Model | P3-EXP-056 (#92) | Whether C2/C3 can be jointly modeled with LVEF |
| Ratio Reliability Re-test | P3-EXP-057 (#187) | Whether the measurement scale is accurate (K4 gate) |
| Distribution Overlap | P3-EXP-058 (#188) | Whether measured variables are distinguishable |
In the previous round, #189 (CO Mediation Decomposition) was registered as “feasible in the next round.” This round begins by reviewing existing literature pulse-harmonic-hemodynamic-intermediate-variable-mediation.md (2026-10-06, YY Round 28), which has already established a mediation framework of “HRI → Arterial Stiffness (CAVI/PWV/AIx) → Cardiovascular Risk.” If #189 were executed literally, it would constitute a parallel expansion adding “another CO pathway.” However, per Charter §6, uncontrolled addition of pathways is prohibited as an invalid scope expansion route.
Therefore, this round alters the form of #189: instead of writing “CO Mediation Pathway,” it writes a determination of “whether CO can serve as a mediator.” This represents a falsification-driven advancement (Charter §3, Item 4: identifying key counter-evidence or risks to prevent erroneous expansion).
2. Algebraic Facts: CO and LVEF Share the Same Numerator
Within hemodynamics, there are three definitions (not empirical relationships, but identities):
SV = EDV − ESV Stroke Volume = End-Diastolic Volume − End-Systolic Volume
LVEF = SV / EDV Ejection Fraction = Stroke Volume / End-Diastolic Volume
CO = SV × HR Cardiac Output = Stroke Volume × Heart Rate
By linking these three equations, we derive the relationship between CO and LVEF:
CO = LVEF × EDV × HR
Key Observation: SV appears simultaneously in the numerator of both CO and LVEF.
┌──→ CO (= SV × HR)
SV ─────┤
└──→ LVEF (= SV / EDV)
This implies:
- CO and LVEF are sibling nodes (common effects/common descendants), not parent-child;
- Their correlation arises from sharing SV, not because “CO causes LVEF”;
- Given HR, CO corresponds one-to-one with SV; given EDV, LVEF corresponds one-to-one with SV.
2.1 Why “Siblings” Cannot Serve as Mediators
Causal mediation requires a pathway: X → M → Y, where M lies on the path from X to Y. However, no such pathway exists between CO and LVEF—they are two parallel readings from the same upstream source (SV).
Inserting CO into C2/C3 → CO → LVEF results in the following actual structure:
C2/C3 ──→ SV ──┬──→ CO
│ └──→ LVEF
└──────────────────→ LVEF (possible direct pathway)
CO now becomes a “common effect’s descendant.” In causal inference, conditioning on a common effect or its descendant opens otherwise closed non-causal pathways — this is known as collider bias / selection bias (conditioning on a descendant of a collider). The manifestation is that estimated mediation effects are artificially generated, with directions that cannot be predicted.
→ Therefore, the finding of a “significant CO mediation effect,” regardless of sign, cannot serve as evidence. It measures bias, not mechanism.
3. What Constitutes a Legitimate Mediator Candidate
To serve as a mediator, a variable must satisfy two conditions: ① lie on the causal pathway from X to Y; and ② not be a definitional component of Y.
| Candidate | On Pathway? | Definitional Coupling with LVEF | Verdict |
|---|---|---|---|
| CO (Cardiac Output) | ❌ Sibling node | ⛔ Shares SV | Not usable |
| HR (Heart Rate) | Partially (component of CO) | No definitional coupling with LVEF | ⚠️ Can serve as a covariate, not a mediator |
| SVR (Systemic Vascular Resistance) | ✅ Influences afterload → SV | None | ✅ Usable (covered by existing literature) |
| Arterial Stiffness (CAVI/PWV) | ✅ Influences afterload/reflected waves | None | ✅ Usable (covered by existing literature) |
| EDV (End-Diastolic Volume) | ✅ Influences preload → SV | ⛔ Denominator in LVEF formula | ⚠️ Cannot serve as a sole mediator |
| SV itself | — | Numerator in LVEF formula | ⛔ Circular reasoning; prohibited |
3.1 An Counterintuitive but Critical Inference
EDV cannot serve as a mediator—it is the denominator in the LVEF formula. Inserting EDV into C2/C3 → EDV → LVEF equates to using one of the numerator or denominator terms (SV/EDV) to “explain” the fraction itself. While mathematically correlated, this yields no mechanistic information.
→ As an outcome variable, LVEF’s “definitional components” (SV, EDV) must be excluded from the mediation layer. This rule should be codified as a pre-modeling constraint in Pool ③.
3.2 Remaining Valid Pathways
Excluding definitional components, the only measurable intermediate layers involve mechanical/resistance variables:
C2/C3 ──→ Arterial Stiffness (CAVI/PWV) ──→ Afterload ──→ SV ──→ LVEF
└─→ Systemic Vascular Resistance (SVR) ────────┘
└─→ (Possible direct pathway)
This framework aligns with the structure proposed in the October 6, 2026 article, without introducing new pathways. Therefore, the correct response to #189 is not “add CO,” but rather “confirm that CO is excluded.”
4. If CO Must Be Used, Its Only Legitimate Application
CO is not useless; it functions as a confounding/precision variable, not a mediator:
| Usage | Legitimacy | Explanation |
|---|---|---|
| As a stratification variable (stratify by CO tertiles before examining C2/C3→LVEF) | ✅ | Explores whether effects vary by flow state (effect modification), without conducting a mediation decomposition |
| As a precision covariate (improving LVEF measurement precision) | ⚠️ | Only when CO correlates with LVEF measurement error; requires caution |
| As a mediator variable | ⛔ | See §2.1 |
| As a surrogate endpoint for the outcome | ⛔ | CO and LVEF are not equivalent (one incorporates HR, the other EDV) |
→ Recommendation: Rewrite #189 as “CO as an effect modifier,” rather than a mediator decomposition. This represents a downgrade but not abandonment.
5. Four Conditions for Falsification (F1–F4)
| ID | Condition | Consequence |
|---|---|---|
| F1 | If an individual can identify a clinical scenario where CO variation occurs prior to and independently of SV variation (i.e., CO is not a product of SV×HR) | Then CO may be reconsidered as a mediator in that scenario; mechanisms and literature must be provided, not merely examples |
| F2 | If empirical findings show the association between C2/C3 and CO disappears after controlling for HR | This confirms that the association of CO stems entirely from HR, further supporting the view that “CO provides no independent information” |
| F3 | If, within the C2/C3 → CO → LVEF model, adding SV causes the mediation effect to flip its sign |
This is a direct indicator of collider bias → the model should be permanently discarded |
| F4 | If #188 (distribution overlap) is judged as O-transparent (three categories cannot be distinguished) | Then any mediation model becomes meaningless (the outcome itself cannot be stratified) → this takes precedence over this card |
F4 has the highest priority: The conclusion value of this card rests on the premise that “LVEF can be stratified at least to some degree.” If #188 has already judged the topic as terminated, this card automatically downgrades to a methodological archive.
6. Retrieval of Empirical Data (Current Round, 4 Keyword Sets, PubMed)
| # | Keywords | Hits | Interpretation |
|---|---|---|---|
| Q1 | cardiac output stroke volume photoplethysmography waveform systolic amplitude |
2 | No direct mediation studies identified |
| Q2 | pulse wave amplitude cardiac output mediation left ventricular ejection fraction |
2 | Neither study employed a mediation design |
| Q3 | photoplethysmography waveform features stroke volume index correlation |
0 | Empty list |
| Q4 | left ventricular ejection fraction stroke volume end-diastolic volume relationship |
1516 | All represent definitional or clinical relationships; no “CO mediation of LVEF” found |
→ “Pulse Harmonics → CO → LVEF Mediation” yields no direct hits in PubMed → evidence_level: B (adjacent-layer evidence chain exists, but no direct study); not framed as a confirmed conclusion.
7. Anchors (6 items, all verified via E-utilities)
| ID | PMID | First Author | Vehicle | Year | Role in This Article |
|---|---|---|---|---|---|
| A1 | 26653405 | VanderWeele TJ | Annu Rev Public Health | 2016 | Practical guide for mediation analysis: distinguishing mediation from interaction, four types of effect decomposition (direct methodological anchor for this card) |
| A2 | 25716909 | Chow B | Heart Fail Rev | 2015 | Meta-analysis on arterial stiffness and HFpEF — supports the validity of “mechanical variables” as legitimate mediators |
| A3 | 17940842 | Awad AA | J Clin Monit Comput | 2007 | PPG waveform ↔ systemic vascular resistance (empirical bridge from waveform to resistance) |
| A4 | 19602972 | Marik PE | Crit Care Med | 2009 | Derived arterial waveform variables ↔ fluid responsiveness (empirical bridge from waveform to SV changes) |
| A5 | 40892475 | Kulin D | Physiol Int | 2025 | PPG pulse wave parameters and composite scores for cardiac function assessment (reused from #92) |
| A6 | 27330520 | Koo TK | J Chiropr Med | 2016 | ICC reporting guidelines (reused from #187/#188; stratified reliability required if effect modification is converted) |
Note: A3 and A4 support only the proposition that “waveforms contain information regarding SV and resistance,” not that they mediate CO via LVEF. This card cites them as an empirical foundation for “legitimate mediator layer candidates,” not as evidence supporting the conclusions of this card.
8. ⚠️ Additional Findings for This Round: Misattribution of Citations in Existing Articles
While verifying A1–A6, I cross-referenced the two PMIDs cited in pulse-harmonic-hemodynamic-intermediate-variable-mediation.md (Pool 3 Health Mainline, not OMOP sub-line):
| PMID | Stated Purpose in Article | Actual Return from E-utilities | Verdict |
|---|---|---|---|
| 33198498 | “CAVI/PWV are independent predictors of cardiovascular events” | Dickow J et al., Circ Arrhythm Electrophysiol 2020 —— “Characterization of Lesions Created by a Heated, Saline Irrigated Needle-Tip Catheter…” (Characterization of lesions created by a heated, saline irrigated needle-tip catheter) | ⛔ Completely Irrelevant |
| 31677287 | Same | Rashed MZ et al., Electrophoresis 2020 —— “Scaling law analysis of electrohydrodynamics and dielectrophoresis…” (Electrohydrodynamics and dielectrophoresis scaling law analysis) | ⛔ Completely Irrelevant |
Why this is more critical than the previous round: Previous rounds characterized citation failure as an “OMOP/R-TRIBE sub-line issue, leaving the harmonic mainline unaffected”. This round proves that characterization is too narrow – the issue also exists within the health mainline. Affected scope:
03-sites/cn/research/science-yixue/pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(2 instances in body + frontmatter PMIDs + related reading)03-sites/lab/research/science-yixue/pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(mirror, also 2 instances)08-ops/experiments/pool3-pulse-harmonic-hemodynamic-intermediate-variable-mediation.md(1 instance)
No changes will be made to these three files this round (they belong to existing body text and require JOE to determine the bleeding stop solution). Only registration, no modification. Verified real replacement candidates retrieved in this round (for use during repair, not yet verified individually, thus no conclusions drawn): CAVI cohort direction 37952789 / 28275590; baPWV meta direction 28438905. → Must run citation-verify.sh before repair.
9. Final Disposition of #189 (State Transition in This Round)
| Item | Pre-Change | Post-Change |
|---|---|---|
| #189 Form | “Pathway decomposition with CO as a mediator variable” | ⛔ Reject Mediator Form |
| #189 Downgraded To | — | “Stratified analysis with CO as an effect modifier variable” (P3 downgrade retained) |
| New Modeling Rule | — | R-189: Components defining LVEF (SV, EDV) must not enter the mediator layer |
| Net Increase in Pathways | +1 (CO) | 0 (Compliant with Charter §6 against scope expansion) |
Value of This Rule: It eliminates all future modeling attempts attempting to explain LVEF using SV, EDV, or CO as mediators. Any subsequent cards involving LVEF from Pool 3 (#92, #187, #188) should apply this rule.
10. Related Reading
- HRI-C2/C3 and LVEF Joint Diagnostic Model (#92 / P3-EXP-056)
- Reliability Rescreening of the C2/C3 Ratio: K4 Pre-experiment (#187 / P3-EXP-057)
- Distributional Overlap of C2/C3 Across Three LVEF Strata (#188 / P3-EXP-058)
- Pulse Harmonics and Hemodynamic Intermediates: Mediating Pathways of Arterial Stiffness (2026-10-06, contains pending citation corrections)
- VanderWeele TJ (2016). Mediation Analysis: A Practitioner’s Guide. Annu Rev Public Health. PMID 26653405
This document is a draft representing a modeling structural determination (via refutation), not a clinical study, and does not constitute diagnostic or therapeutic advice.
No claim is made that C2/C3 predicts LVEF or cardiac output (CO).
The status “accepted” is not indicated; the values 779/782 are not explicitly stated.
Entry into 779 requires an intake process; entry into 782 requires de-AI-ization.
Leave a Reply